Nuclear Medicine AtlasInteractive atlas

Reading the Low-Dose Non-Contrast CT

A systematic organ-by-organ approach to the localization CT, what you can and cannot say without contrast

Evidence BC#correlative-ct#interpretation#CT#incidentalUpdated 2026-07-28 · Physician-reviewed
High-yield mode — key points, high-yield facts, tables & quizzes only. Toggle off for full text.

Quick Answer

Read the low-dose non-contrast CT the same way every time, organ by organ, on the right window, asking two questions at each stop: is there a finding here, and does it explain (or contradict) the tracer picture? Without contrast you can assess air, fat, fluid, calcium, size, and gross morphology — enough to characterize many findings as benign (calcified granuloma, fatty adenoma, simple cyst) or to flag them for dedicated imaging. You cannot reliably assess enhancement, small hypervascular lesions, or subtle parenchymal disease — so the non-contrast read ends either in a confident benign call or a recommendation for dedicated CT/MRI.

A fixed search pattern

Use a consistent checklist so nothing is skipped: lungs → mediastinum & heart (coronary calcium) → liver, spleen, pancreas, adrenals, kidneys → nodes → bones → vessels → soft tissues. Read each on its proper window (lung window for parenchyma, soft-tissue for organs/nodes, bone window for skeleton), and at each organ ask whether a finding is present and whether it matches the tracer data. A fixed pattern is what prevents the "satisfaction of search" miss after you've found the thing you were looking for.

Organ-by-organ, without contrast

Lungs (lung window). Nodules (size, calcification, fat, spiculation), emphysema, fibrosis, effusions, consolidation. A calcified or fat-containing nodule is benign; a solid non-calcified nodule needs size-based follow-up (Fleischner) or correlation with tracer avidity. Sub-solid/ground-glass and small nodules are easy to miss on low dose — deliberately window through the lungs.

Mediastinum & heart (soft-tissue window). Nodes (size, calcification), masses, and coronary artery calcium — even a non-gated low-dose CT shows CAC, an actionable cardiovascular-risk marker worth reporting. Pericardial effusion, aortic caliber.

Liver, spleen, pancreas, adrenals, kidneys (soft-tissue window). On non-contrast CT: simple cysts (fluid density, 0–20 HU) are benign; an adrenal nodule with fat density (< 10 HU) is a benign adenoma; renal/hepatic lesions are often indeterminate without contrast → recommend dedicated imaging. Note biliary/renal stones, hydronephrosis, organomegaly, and steatosis (low-density liver).

Bones (bone window). Scan the spine, pelvis, ribs, and visualized long bones for sclerotic vs lytic lesions, fractures, and degenerative change. Correlate with the tracer: a sclerotic focus with matching uptake may be a treated or blastic metastasis; a lytic lesion with uptake is concerning; a purely degenerative change (facet, endplate) explains benign uptake.

Vessels & soft tissues. Aortic and iliac aneurysm/dissection caliber, vascular and valvular calcification, hernias, ascites, and body-wall or subcutaneous masses. Aneurysms and dissections are high-consequence incidentals not to miss.

What non-contrast CT can and cannot do

Can: distinguish air, fat, fluid, soft tissue, calcium, and metal by density; measure size; show gross morphology, stones, emphysema, fractures, aneurysm caliber, coronary/vascular calcium, and the benign signatures (fatty adenoma, calcified granuloma, simple cyst, fatty nodal hilum). Cannot: show enhancement (so hypervascular liver/renal/pancreatic lesions, bowel-wall inflammation, and small metastases can be missed or mischaracterized), reliably characterize an indeterminate soft-tissue lesion, or exclude subtle disease at low dose. When a finding's management hinges on enhancement or a precise HU threshold, defer to a dedicated diagnostic study.

Integrate with the tracer at every stop

The point of correlative reading is fusion: a CT finding and a tracer finding interpreted together are far more specific than either alone. Uptake with a benign CT substrate (calcified node, brown fat, physiologic bowel, degenerative joint) is reassuring; uptake with a soft-tissue mass, lytic bone, or enlarging node is worrying; a CT lesion without expected uptake may be necrotic, low-grade, or below resolution. This integration is developed on the companion page, Correlating tracer uptake with CT.

High-Yield Pearls

  • Use a fixed organ-by-organ checklist on the correct window every time — it defeats satisfaction-of-search.
  • Non-contrast CT reads density: fat = benign adenoma/AML/lipoma; fluid = cyst; calcium = benign/granulomatous/treated.
  • Report coronary artery calcium, aortic aneurysm, and actionable incidentals even on a low-dose localization CT.
  • When enhancement or a precise threshold matters, recommend dedicated CT/MRI rather than over-reading the low-dose scan.

Common Pitfalls

  • Satisfaction of search — stopping after the expected finding and missing a second one.
  • Reading everything on soft-tissue window and missing lung and bone findings.
  • Calling a non-contrast liver/renal lesion benign or malignant when it is simply indeterminate without contrast.
  • Dismissing a low-dose CT as "not diagnostic" and skipping the systematic review you are responsible for.
  • Foundations: CT for the nuclear medicine reader; integration: Correlating tracer uptake with CT.
  • Incidental action lists: Incidental findings on PET/CT; artifacts: Attenuation & misregistration artifacts.

Self-Check

Q1. Outline a systematic search pattern for the localization CT.

Answer: Lungs → mediastinum & heart (coronary calcium) → liver/spleen/pancreas/adrenals/kidneys → nodes → bones → vessels → soft tissues, each on its proper window, correlating with the tracer at every stop.

Q2. An adrenal nodule measures −5 HU on non-contrast CT. Interpretation?

Answer: Fat (macroscopic) density → benign adrenal adenoma; low non-contrast HU is characteristic (the classic ≤10-HU adenoma threshold), so it needs no further workup on that basis.

Q3. Name two things a non-contrast CT cannot reliably do.

Answer: Show enhancement (missing/mischaracterizing hypervascular or small lesions) and reliably characterize an indeterminate soft-tissue lesion — both warrant dedicated contrast imaging.

Q4. Even on a non-gated low-dose CT, what cardiovascular finding should you report?

Answer: Coronary artery calcium — an actionable cardiovascular-risk marker visible without gating or contrast (and aortic aneurysm caliber).

Key References

  • Fleischner Society guidelines for incidental pulmonary nodules on CT.
  • SNMMI/ACR guidance on systematic review of the CT component of hybrid imaging and reporting of incidental findings.

Evidence & sources

BFleischner Society guidelines — management of incidental pulmonary nodules detected on CT.
CNon-contrast density characterization — HU thresholds for adrenal adenoma (≤10 HU), simple cysts, fat-containing and calcified lesions; low-dose noise caveats.
Cite this page. Nuclear Medicine Atlas. “Reading the Low-Dose Non-Contrast CT.” v1.76, 2026-10-25. Permalink: https://nuc.med/reading-low-dose-noncontrast-ct/ Report an issue
Nuclear Medicine Atlas · v1.76 · built 2026-10-25Terms · Privacy · Disclaimer